Published online before print July 19, 2004, doi: 10.1161/01.CIR.0000136807.78534.50
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 2004;110:399-404.)
© 2004 American Heart Association, Inc.
Original Articles |
Systemic Lupus Erythematosus
An Independent Risk Factor for Endothelial Dysfunction in Women
From the University of Manchester arc Epidemiology Unit (M.E.-M., Y.A.), Department of Vascular Surgery (H.B., M.W.), Rheumatism Research Centre (Y.A., R.M.B., I.N.B.), and Department of Medicine (P.N.D., M.M.), Manchester Royal Infirmary, Central Manchester and Manchester Children’s University Hospitals NHS Trust, Manchester, UK.
Correspondence to Dr I.N. Bruce, MD, FRCP, Senior Lecturer in Rheumatology, University of Manchester, Rheumatism Research Centre, Central Manchester and Manchester Children’s University Hospitals NHS Trust, Oxford Rd, Manchester, M13 9WL UK. E-mail ian.bruce{at}man.ac.uk
Received February 9, 2004; de novo received April 13, 2004; accepted May 15, 2004.
Background— Systemic lupus erythematosus (SLE) patients have a significantly increased risk of coronary heart disease (CHD) that is not fully explained by classic risk factors. Endothelial dysfunction is an early stage in the process of atherogenesis. Our aim was to determine whether endothelial dysfunction occurs in SLE and whether it is associated with the occurrence of classic Framingham risk factors.
Methods and Results— We studied 62 women with SLE (1997 revised criteria) and 38 healthy women. Demographic and risk factor data were collected. In patients, disease activity and treatment-related parameters were also assessed. Endothelial function was assessed by flow-mediated dilation (FMD) in the brachial artery in response to reactive hyperemia. Carotid intima-media thickness (IMT) and the presence of carotid plaques were also assessed in SLE patients. FMD was impaired in SLE patients (median, 3.6%; range, –6.3% to 13.7%; versus median, 6.9%; range, –6.6% to 17.8%, P<0.01). Using multiple regression analysis that included all subjects in which we retained all the classic CHD risk factors, we found that systolic blood pressure (P=0.019) and SLE (P=0.017) were significantly associated with impaired FMD. Within SLE patients, IMT showed a negative correlation with percent FMD (r=–0.37, P<0.01). In stepwise multiple regression of SLE patients only that also included SLE factors and IMT, IMT alone was independently associated with FMD (P=0.037).
Conclusions— Patients with SLE have endothelial dysfunction that remained significant even after adjustment for other classic CHD risk factors. Within SLE patients, endothelial dysfunction correlates negatively with IMT, another marker of early atherosclerosis. Understanding the mechanism(s) of endothelial dysfunction in SLE may suggest novel strategies for CHD prevention in this context.
Key Words: coronary disease • endothelium • lupus erythematosus, systemic
This article has been cited by other articles:
 |
|
 |
|
  M. Pertovaara, M. Kahonen, M. Juonala, T. Laitinen, L. Taittonen, T. Lehtimaki, J. S. A. Viikari, O. T. Raitakari, and M. Hurme Autoimmunity and atherosclerosis: the presence of antinuclear antibodies is associated with decreased carotid elasticity in young women. The Cardiovascular Risk in Young Finns Study Rheumatology, December 1, 2009; 48(12): 1553 - 1556. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. APOSTOLAKIS, E. SHANTSILA, and G. Y.H. LIP Vascular Imaging as a Cardiovascular Risk Stratification Tool in Systemic Lupus Erythematosus J Rheumatol, October 1, 2009; 36(10): 2141 - 2143. [Full Text] [PDF]
|
|
|
|
 |
|
 A. Recio-Mayoral, J. C. Mason, J. C. Kaski, M. B. Rubens, O. A. Harari, and P. G. Camici Chronic inflammation and coronary microvascular dysfunction in patients without risk factors for coronary artery disease Eur. Heart J., August 1, 2009; 30(15): 1837 - 1843. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A Cypiene, M Kovaite, A Venalis, J Dadoniene, R Rugiene, Z Petrulioniene, L Ryliskyte, and A Laucevicius Arterial wall dysfunction in systemic lupus erythematosus Lupus, May 1, 2009; 18(6): 522 - 529. [Abstract] [PDF]
|
|
|
|
|
|
J Aizer, E. Karlson, L. Chibnik, K. Costenbader, D Post, M. Liang, V Gall, and M. Gerhard-Herman A controlled comparison of brachial artery flow mediated dilation (FMD) and digital pulse amplitude tonometry (PAT) in the assessment of endothelial function in systemic lupus erythematosus Lupus, March 1, 2009; 18(3): 235 - 242. [Abstract] [PDF]
|
|
|
|
|
|
F Cacciapaglia, E. Zardi, G Coppolino, F Buzzulini, D Margiotta, L Arcarese, M Vadacca, A Amoroso, and A Afeltra Stiffness parameters, intima-media thickness and early atherosclerosis in systemic lupus erythematosus patients Lupus, March 1, 2009; 18(3): 249 - 256. [Abstract] [PDF]
|
|
|
|
|
|
M. A. SHAH, A. M. SHAH, and E. KRISHNAN Poor Outcomes After Acute Myocardial Infarction in Systemic Lupus Erythematosus J Rheumatol, March 1, 2009; 36(3): 570 - 575. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. NIKPOUR, D. D. GLADMAN, D. IBANEZ, I. N. BRUCE, R. J. BURNS, and M. B. UROWITZ Myocardial Perfusion Imaging in Assessing Risk of Coronary Events in Patients with Systemic Lupus Erythematosus J Rheumatol, February 1, 2009; 36(2): 288 - 294. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K de Leeuw, J Blaauw, A. Smit, C. Kallenberg, and M Bijl Vascular responsiveness in the microcirculation of patients with systemic lupus erythematosus is not impaired Lupus, November 1, 2008; 17(11): 1010 - 1017. [Abstract] [PDF]
|
|
|
|
 |
|
 D. A. Mandelbrot, P. W. Santos, R. K. Burt, Y. Oyama, G. A. Block, S. N. Ahya, R. M. Rosa, and A. E. Traynor Resolution of SLE-related soft-tissue calcification following haematopoietic stem cell transplantation Nephrol. Dial. Transplant., August 1, 2008; 23(8): 2679 - 2684. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. I. van Leuven, R. Franssen, J. J. Kastelein, M. Levi, E. S. G. Stroes, and P. P. Tak Systemic inflammation as a risk factor for atherothrombosis Rheumatology, January 1, 2008; 47(1): 3 - 7. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. A. Ferreira, T. P. Navarro, R. W. Telles, L. E. C. Andrade, and E. I. Sato Atorvastatin therapy improves endothelial-dependent vasodilation in patients with systemic lupus erythematosus: an 8 weeks controlled trial Rheumatology, October 1, 2007; 46(10): 1560 - 1565. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Kasparian, A. Floros, E. Gialafos, M. Kanakis, S. Tassiopoulos, N. Kafasi, and G. Vaiopoulos Raynaud's phenomenon is correlated with elevated systolic pulmonary arterial pressure in patients with systemic lupus erythematosus Lupus, July 1, 2007; 16(7): 505 - 508. [Abstract] [PDF]
|
|
|
|
 |
|
 P. E Westerweel, R. K M A C Luijten, I. E Hoefer, H. A Koomans, R. H W M Derksen, and M. C Verhaar Haematopoietic and endothelial progenitor cells are deficient in quiescent systemic lupus erythematosus Ann Rheum Dis, July 1, 2007; 66(7): 865 - 870. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Ahmad, J. Shelmerdine, H. Bodill, M. Lunt, M. G. Pattrick, L. S. Teh, R. M. Bernstein, M. G. Walker, and I. N. Bruce Subclinical atherosclerosis in systemic lupus erythematosus (SLE): the relative contribution of classic risk factors and the lupus phenotype Rheumatology, June 1, 2007; 46(6): 983 - 988. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M K Piper, K Raza, S L Nuttall, R Stevens, V Toescu, S Heaton, J Gardner-Medwin, L Hiller, U Martin, J Townend, et al. Impaired endothelial function in systemic lupus erythematosus Lupus, February 1, 2007; 16(2): 84 - 88. [Abstract] [PDF]
|
|
|
|
 |
|
 J. Mikdashi, B. Handwerger, P. Langenberg, M. Miller, and S. Kittner Baseline Disease Activity, Hyperlipidemia, and Hypertension Are Predictive Factors for Ischemic Stroke and Stroke Severity in Systemic Lupus Erythematosus Stroke, February 1, 2007; 38(2): 281 - 285. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M McMahon, J Grossman, W Chen, and B H Hahn Inflammation and the pathogenesis of atherosclerosis in systemic lupus erythematosus Lupus, November 1, 2006; 15(11_suppl): 59 - 69. [Abstract] [PDF]
|
|
|
|
|
|
N Bjarnegard, C Bengtsson, J Brodszki, G Sturfelt, O Nived, and T Lanne Increased aortic pulse wave velocity in middle aged women with systemic lupus erythematosus Lupus, October 1, 2006; 15(10): 644 - 650. [Abstract] [PDF]
|
|
|
|
 |
|
 S. A. Wright, F. M. O'Prey, D. J. Rea, R. D. Plumb, A. J. Gamble, W. J. Leahey, A. B. Devine, R. C. McGivern, D. G. Johnston, M. B. Finch, et al. Microcirculatory Hemodynamics and Endothelial Dysfunction in Systemic Lupus Erythematosus Arterioscler Thromb Vasc Biol, October 1, 2006; 26(10): 2281 - 2287. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Aeberli, M. Leech, and E. F. Morand Macrophage migration inhibitory factor and glucocorticoid sensitivity Rheumatology, August 1, 2006; 45(8): 937 - 943. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z Bagi, P Hamar, M Kardos, and A Koller Lack of flow mediated dilation and enhanced angiotensin II-induced constriction in skeletal muscle arterioles of lupus-prone autoimmune mice Lupus, June 1, 2006; 15(6): 326 - 334. [Abstract] [PDF]
|
|
|
|
 |
|
 D. P D'Cruz Systemic lupus erythematosus. BMJ, April 15, 2006; 332(7546): 890 - 894. [Full Text] [PDF]
|
|
|
|
|
|
S I van Leuven, J J. Kastelein, D P D'Cruz, G R Hughes, and E S Stroes Atherogenesis in rheumatology Lupus, March 1, 2006; 15(3): 117 - 121. [Abstract] [PDF]
|
|
|
|
|
|
I. N. Bruce 'Not only...but also': factors that contribute to accelerated atherosclerosis and premature coronary heart disease in systemic lupus erythematosus Rheumatology, December 1, 2005; 44(12): 1492 - 1502. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I N Bruce Atherogenesis and autoimmune disease: the model of lupus Lupus, September 1, 2005; 14(9): 687 - 690. [Abstract] [PDF]
|
|
|
|
|
|
J. Frostegard Atherosclerosis in Patients With Autoimmune Disorders Arterioscler Thromb Vasc Biol, September 1, 2005; 25(9): 1776 - 1785. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Teerlink ADMA metabolism and clearance Vascular Medicine, July 1, 2005; 10(1_suppl): S73 - S81. [Abstract] [PDF]
|
|
|
|
|
|
C. D. Buckley, G. E. Rainger, G. B. Nash, and K. Raza Endothelial cells, fibroblasts and vasculitis Rheumatology, July 1, 2005; 44(7): 860 - 863. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. J. Roman, R. B. Devereux, J. E. Schwartz, M. D. Lockshin, S. A. Paget, A. Davis, M. K. Crow, L. Sammaritano, D. M. Levine, B.-A. Shankar, et al. Arterial Stiffness in Chronic Inflammatory Diseases Hypertension, July 1, 2005; 46(1): 194 - 199. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Teerlink ADMA metabolism and clearance Vascular Medicine, May 1, 2005; 10(2_suppl): S73 - S81. [Abstract] [PDF]
|
|